We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » 483 for U.S. Infusion Cites Issues With Reporting, Quality Control
483 for U.S. Infusion Cites Issues With Reporting, Quality Control
The FDA handed U.S. Infusion a Form 483 for violations including failure to notify the agency within 30 days after learning of a device malfunction that could result in patient injury or death.